Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

Abstract Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, bivalent mRNA-based booster vaccines encoding the ancestral spike protein in combination with that of Omicron BA.1 or...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, Laura L. A. van Dijk, Lennert Gommers, Leanne P. M. van Leeuwen, Sharona Rugebregt, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Virgil A. S. H. Dalm, Melvin Lafeber, Neeltje A. Kootstra, Anke L. W. Huckriede, Bart L. Haagmans, Debbie van Baarle, Marion P. G. Koopmans, SWITCH-ON Research Group, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-05-01
coleção:	Nature Communications
Acesso em linha:	https://doi.org/10.1038/s41467-024-48414-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!